| Trial ID: | L3892 |
| Source ID: | NCT00365781
|
| Associated Drug: |
Isis 113715
|
| Title: |
Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: ISIS 113715
|
| Outcome Measures: |
Primary: Compare the dermatologic responses to 200 mg/1.0 mL and 200 mg/2.0 mL ISIS 113715 administered subcutaneously into separate abdominal sites, with both injections given on the same day.|Evaluate and examine the effect of treatment on laboratory results, vital signs, and adverse events. |
|
| Sponsor/Collaborators: |
Sponsor: Ionis Pharmaceuticals, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2006-09
|
| Results First Posted: |
|
| Last Update Posted: |
2007-10-17
|
| Locations: |
Therapeutics Clinical Research, San Diego, California, 92121, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00365781
|
